Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Immunotherapy|December 16, 2014
Immunotherapy and lung cancer: current developments and novel targeted therapiesDuarte Domingues, Alice Turner, Maria Dília Silva, et al.
Future Oncology (London, England)|November 11, 2022
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemicKatia Roque, Rossana Ruiz, Iris Otoya-Fernandez, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?Ramon Andrade De Mello, Luis Castelo-Branco, Pedro Castelo-Branco, et al.
Cancers|April 3, 2021
Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung CancerGuangsheng Zhu, Dian Ren, Xi Lei, et al.
Immunotherapy|March 15, 2016
The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysisPedro N Aguiar, Ilka Lopes Santoro, Hakaru Tadokoro, et al.
ESMO Open|December 7, 2017
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targetsPedro Nazareth Aguiar, Ramon Andrade De Mello, Carmelia Maria Noia Barreto, et al.
Future Oncology (London, England)|February 9, 2018
Lung cancer: a brief review of epidemiology and screeningCláudia Gouvinhas, Ramon Andrade De Mello, Daniela Oliveira, et al.
Journal of Clinical Medicine|June 25, 2020
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung CancerRamon Andrade De Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers?Hélder Almeida-Lousada, André Mestre, Sara Ramalhete, et al.
Immunotherapy|August 4, 2016
A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarkerPedro N Aguiar, Ilka Lopes Santoro, Hakaru Tadokoro, et al.
Pageof 7